Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Olink Proteomics AB
AB
Active
Org 5590468632
Salagatan 16 A, 753 30
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
394 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Olink Proteomics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
424M
848M
1B
2B
492M
2020
780M
2021
1.4B
2022
1.5B
2023
1.4B
2024
EBITDA
SEK millions
38M
-137M
-311M
-486M
-660M
30M
2020
-92M
-407%
2021
-13M
+86%
2022
-66M
-408%
2023
-528M
-700%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
491 815
780 087
1 357 752
1 473 511
1 382 259
Staff expenses
—
—
—
—
—
EBITDA
29 650
−91 919
−13 463
−65 890
−527 747
Depreciation & amort.
—
—
—
—
—
EBIT
29 650
−91 919
−13 463
−65 890
−527 747
Net financials
−7 162
6 022
18 046
−38 736
11 585
Profit before tax
−544
−34 892
4 584
−90 059
−614 361
Tax
−0
6 538
−298
20 938
134 467
Net profit
−544
−28 354
4 286
−69 121
−479 894
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
677 352
1 020 734
1 256 042
1 875 073
1 690 919
Equity
401 931
373 577
377 864
1 591 274
1 111 379
Long-term debt
0
0
0
0
0
Short-term debt
236 916
647 156
878 178
283 799
579 540
Total debt
236 916
647 156
878 178
283 799
579 540
Financial ratios
5-year trend
EBITDA margin
-38.2%
This company
15.8%
Market median
-342% vs market
2020
2024
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
2020
2024
Return on equity
-43.2%
This company
18.4%
Market median
-335% vs market
2020
2024
Net profit margin
-34.7%
This company
8.1%
Market median
-528% vs market
2020
2024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
2020
2024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Olink Proteomics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
